Skip to Main Content

Paper Details

Safety and efficacy of therapies for chylomicronemia.
Expert Review of Clinical Pharmacology
12
2022
AKCEA-, ANGPTL3, APOCIII-LRx, ARO, ARO-ANG3, ARO-APOC3, FCS, Patients, Primary chylomicronemia, acute pancreatitis, angiopoietin-like protein 3, apo C-III, apolipoprotein (apo) C-III, chylomicronemia, familial chylomicronemia syndrome, hypertriglyceridemia, multifactorial chylomicronemia, olezarsen, patients, short interfering RNA, siRNA, thrombocytopenia, triglyceride, volanesorsen
Author NameAffiliation
Robert A HegeleSchulich School of Medicine and Dentistry, Western University
  • 1 - 1

Datasets

Release 1.2